Your browser doesn't support javascript.
loading
Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants.
Chen, Liqing; Qi, Xiaoxiao; Liang, Dan; Li, Guiqi; Peng, Xiaofang; Li, Xiaohui; Ke, Bixia; Zheng, Huanying; Liu, Zhongqiu; Ke, Changwen; Liao, Guochao; Liu, Liang; Feng, Qian.
Afiliação
  • Chen L; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Qi X; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Liang D; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Li G; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 510006, China.
  • Peng X; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Li X; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 510006, China.
  • Ke B; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Zheng H; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 510006, China.
  • Liu Z; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 510006, China.
  • Ke C; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Liao G; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 510006, China.
  • Liu L; Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Feng Q; Guangdong Hengda Biomedical Technology Co., Ltd., Guangzhou 510006, China.
Vaccines (Basel) ; 10(9)2022 Sep 08.
Article em En | MEDLINE | ID: mdl-36146579

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article